Literature DB >> 18086328

Steroid treatment for persistent ARDS: a word of caution.

B Taylor Thompson, Marek Ancukiewicz, Leonard D Hudson, Kenneth P Steinberg, Gordon R Bernard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18086328      PMCID: PMC2246218          DOI: 10.1186/cc6186

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.
  4 in total

1.  Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.

Authors:  Kenneth P Steinberg; Leonard D Hudson; Richard B Goodman; Catherine Lee Hough; Paul N Lanken; Robert Hyzy; B Taylor Thompson; Marek Ancukiewicz
Journal:  N Engl J Med       Date:  2006-04-20       Impact factor: 91.245

2.  An expanded definition of the adult respiratory distress syndrome.

Authors:  J F Murray; M A Matthay; J M Luce; M R Flick
Journal:  Am Rev Respir Dis       Date:  1988-09

3.  Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome.

Authors:  Roy G Brower; Paul N Lanken; Neil MacIntyre; Michael A Matthay; Alan Morris; Marek Ancukiewicz; David Schoenfeld; B Taylor Thompson
Journal:  N Engl J Med       Date:  2004-07-22       Impact factor: 91.245

4.  Steroids in late ARDS?

Authors:  Non Wajanaponsan; Michael C Reade; Eric B Milbrandt
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  4 in total
  6 in total

Review 1.  [Corticosteroid administration for acute respiratory distress syndrome : therapeutic option?].

Authors:  P Möhnle; J Briegel
Journal:  Anaesthesist       Date:  2012-04       Impact factor: 1.041

Review 2.  Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature.

Authors:  G Umberto Meduri; Lisa Bridges; Mei-Chiung Shih; Paul E Marik; Reed A C Siemieniuk; Mehmet Kocak
Journal:  Intensive Care Med       Date:  2015-10-27       Impact factor: 17.440

3.  Diffuse alveolar damage in nonresolving ARDS provides support for prolonged glucocorticoid treatment.

Authors:  Gianfranco Umberto Meduri
Journal:  Intensive Care Med       Date:  2015-05-14       Impact factor: 17.440

Review 4.  Prolonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired Weakness.

Authors:  Gianfranco Umberto Meduri; Andreas Schwingshackl; Greet Hermans
Journal:  Front Pediatr       Date:  2016-08-02       Impact factor: 3.418

Review 5.  Rationale for Prolonged Glucocorticoid Use in Pediatric ARDS: What the Adults Can Teach Us.

Authors:  Andreas Schwingshackl; Gianfranco Umberto Meduri
Journal:  Front Pediatr       Date:  2016-06-14       Impact factor: 3.418

6.  Glucocorticoids in the treatment of acute respiratory distress syndrome.

Authors:  F Roche-Campo; H Aguirre-Bermeo; J Mancebo
Journal:  Reanimation       Date:  2011-10-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.